Choosing Wisely: ctDNA/ Precision Oncology in colorectal cancers
Choosing Wisely: ctDNA/ Precision Oncology in colorectal cancers
I-DXd shows strong brain metastasis responses in extensive-stage small cell lung cancer with manageable safety
Tarlatamab for SCLC: Subgroup analysis shows benefit regardless of previous chemo or anti-PD-(L)1 use
Tarlatamab improves symptoms and QoL over chemo in previously treated SCLC
Tarlatamab improves survival over chemo in 2L SCLC regardless of prior immunotherapy or chemo
Temab-A plus bevacizumab shows promising response rates in advanced colorectal cancer
ESMO 2025: Latest developments in endometrial cancer
ESMO 2025: Highlights and analysis
PRAME-targeted TCR therapy shows high response rates in metastatic uveal melanoma
Best practice in precision medicine for prostate cancer
ctDNA test guides post-surgical immunotherapy for muscle-invasive bladder cancer
Visugromab plus nivolumab significantly increases pathologic response in muscle-invasive bladder cancer